{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:00:06Z","timestamp":1771275606725,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.2515\/therapie:2003023","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T11:23:49Z","timestamp":1174044229000},"page":"159-163","source":"Crossref","is-referenced-by-count":18,"title":["Hyperprolactin\u00e9mies d\u2019origine m\u00e9dicamenteuse : \u00e9tude cas\/non-cas dans la banque nationale de pharmacovigilance"],"prefix":"10.1016","volume":"58","author":[{"given":"Abir","family":"Petit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doroth\u00e9e","family":"Piednoir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie:2003023_bb0660","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/j.1600-0412.1998.770301.x","article-title":"Hyperprolactinemia: etiology, diagnosis, and treatment alternatives","volume":"77","author":"Conner","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.2515\/therapie:2003023_bb0665","first-page":"1075","article-title":"Guidelines for the diagnosis and treatment of hyperprolactinemia","volume":"44","author":"Biller","year":"1999","journal-title":"J Reprod Med"},{"key":"10.2515\/therapie:2003023_bb0670","series-title":"Harrison Medecine Interne","first-page":"2271","article-title":"R\u00e9gulation neuroendocrinienne et pathologie ant\u00e9hypophysaire et hypothalamique","author":"Fauci","year":"1998"},{"key":"10.2515\/therapie:2003023_bb0675","series-title":"Endocrinologie","first-page":"359","article-title":"Hyperprolactin\u00e9mie","author":"Chanson","year":"2000"},{"key":"10.2515\/therapie:2003023_bb0680","series-title":"Epid\u00e9miologie en m\u00e9decine","first-page":"52","article-title":"Mesures de la fr\u00e9quence de la maladie","author":"Hennekens","year":"1998"},{"key":"10.2515\/therapie:2003023_bb0685","series-title":"L\u2019\u00e9pid\u00e9miologie clinique","first-page":"48","article-title":"Traitement","author":"Morabia","year":"1996"},{"key":"10.2515\/therapie:2003023_bb0690","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2125.1997.00615.x","article-title":"Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case\/non-case in the French pharmacovigilance system database","volume":"44","author":"Moore","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie:2003023_bb0695","first-page":"299","article-title":"Hyperprolactin\u00e9mies iatrog\u00e8nes","volume":"31","author":"Vincens","year":"1981","journal-title":"Rev Prat"},{"key":"10.2515\/therapie:2003023_bb0700","first-page":"500","article-title":"Hyperprolactin\u00e9mie induite par l\u2019indoramine","volume":"53","author":"Pradalier","year":"1998","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie:2003023_bb0705","first-page":"167","article-title":"Agr\u00e9al\u00ae: acceptabilit\u00e9. Revue de la litt\u00e9rature","volume":"80","author":"Brient-Clabaux","year":"1985","journal-title":"Rev Fr Gyn\u00e9col Obstet"},{"key":"10.2515\/therapie:2003023_bb0710","first-page":"361","article-title":"Impuissance et gyn\u00e9comastie secondaires \u00e0 une hyperprolactin\u00e9mie par la ranitidine","volume":"49","author":"Berra","year":"1994","journal-title":"Th\u00e9rapie"},{"key":"10.2515\/therapie:2003023_bb0715","first-page":"83","article-title":"Drug-related hyperprolactinemia","volume":"16","author":"Davies","year":"1997","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"10.2515\/therapie:2003023_bb0720","first-page":"563","article-title":"Cimetidine-induced galactorrhea","volume":"84","author":"Ehrinpreis","year":"1989","journal-title":"Am J Gastroenterol"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716300804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T06:34:42Z","timestamp":1554273282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716300804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0040595716300804"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2003023","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}